Clinical Trial Update: Evaluation of Schemes of Administration of Intravenous Ketamine in Depression [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating different schemes of intravenous ketamine administration for treatment-resistant depression is ongoing/unclear status.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Treatment-resistant Depression

Drugs mentioned

• Ketamine (ketamine)

Snippet

Sponsor: National Institute of Neurology and Neurosurgery, Mexico | Conditions: Treatment Resistant Depression | Phase 3 | Status: UNKNOWN